Ferretts IPS Liquid - Iron Protein Succinylate

Advancement in the Treatment Of Iron Deficiency Anemia

Iron Deficiency: Global & US Prevalence

• Conservative estimates indicate that at least 700 million individuals worldwide have overt iron deficiency, affecting 20-50% of population
• Iron deficiency in the US is estimated to be:
  • Ages 1 - 2: 9% (males & females)
  • Ages 3 - 10: 6% (males & females)
  • Ages 11 - 14: 4-12% (males) & 6% (females)
  • Ages 15 - 44: 2% (males) & 3-14% (females)
  • Ages 45 - 74: 2% (males) & 6% (females)

Source: National Health and Nutrition Examination Study (NHANES)

Iron Deficiency: Prevalence in Athletes

• Most athletes, especially females, have low - midrange hemoglobin values
• Referred to as "sports anemia" and affects endurance athletes in particular, thus impairing sports performance
• Incidences have been found to be 8-58% in male athletes and 40-80% in female athletes, which is far higher than in general population
• Even marginal iron deficiency has been found to impair aerobic adaptation, and iron supplementation has been found to increase aerobic adaptation and exercise performance

Source: Brownlee, T., et al. Am J Clin Nutr 2002; 75:734-42

Anemia: When Body Iron is Inadequate

• Iron is a mineral that is an essential constituent of blood and muscle and is required for the transport of oxygen
• The primary role of iron relates to the ability of red blood cells to adequately carry oxygen for use throughout the entire body
• When anemia is finally detected, an unbalanced condition has already been reached, and must be addressed

Symptoms of Iron Deficiency Range from Negligible To Severe Form

• Iron deficiency develops insidiously and is often free of symptoms
• Anemia symptoms include weakness, palpitations, lassitude, light-headedness, fatigue, and sometimes subtle behavioral changes
• In children, iron deficiency can lead to behavior disorders, including lack of focus and poor memory

Several Factors Contribute To Iron Deficiency

Increased Iron Requirement:

• Occurs during the growth spurts of infancy and adolescence
• Occurs during pregnancy, where daily iron requirement increases about twofold
  • A pregnant women's recommended daily allowance doubles from 15 to 30 mg/day, and approx. 1,000 mg iron is needed to replace net losses and increased needs

Inadequate Iron Intake:

• Diets low in animal proteins

Decreased Iron Absorption:

• Partial or total gastrectomy
• Chronic diarrhea or intestinal malabsorption

Blood Loss:

• Menstrual blood loss accounts for the primary reason for iron deficiency among women
• Gastrointestinal bleeding is the primary cause of iron deficiency among adult males
• Volunteer blood donors

Iron Deficiency Anemia "High-Risk" Groups

• People of low socio-economic status or limited education
• Women with history of child-bearing difficulties, hemorrhaging, or multiple gestations
• People with diets that are low in both meat and ascorbic acid
• People who donate blood more than three times per year
• Adolescents, especially male & female endurance athletes
• Elderly
• People who use aspirin regularly

ANEMIA Targeted Screening

• To fully detect and evaluate iron deficiency, screening should not be limited to anemia markers such as hemoglobin, red cell count, hematocrit, and erythrocyte morphology
• A specific marker such as serum ferritin is strictly linked to iron body storage and condition, and is the most precise indicator of actual iron status

Ferretts IPS Product Description

• Ferretts IPS chemically corresponds to Iron Protein Succinylate (IPS) which is an iron compound bonded to a casein
• Due to the succinylation process, the compound has a solubility profile strictly dependant on pH
• Ferretts IPS has the advantage of precipitating in acid conditions and of being soluble at neutral and alkaline pH

Ferretts IPS in Gastric Environment
Insoluble at gastric pH

Ferretts IPS is insoluble at gastric pH, as it is gastro-protected through a casein protein layer (patented succinylation technology). Ferretts IPS, because of its unique gastro-protection, bypasses the gastric mucosa, where iron gastric intolerance most frequently occurs.

Ferretts IPS in Gastric Environment
Soluble at duodenal pH

Ferretts IPS, due to its gastro-protection is hydrolyzed by pancreatic enzymes, at duodenal pH levels only, and therefore the iron is rapidly absorbed into the bloodstream. Ferretts IPS is finally dissolved in the intestine where iron is rapidly absorbed.

Ferretts IPS: Superior Safety and Compliance

• Superior gastric tolerability is ensured, through the absence of free iron remaining in the stomach
• Iron Protein Succinylate's improved gastric tolerance has been demonstrated in clinical settings
• Clinical studies in about 3,500 patients showed absence of gastric side-effects in 93.7% of patients, while only 6.3% claimed one or more adverse events

Ferretts IPS IPS Absorption Is Not Affected By Food Intake

Blood iron concentration (mean ± SD; n = 10) at different time points after administration of 80 mg of iron as protein succinylate complex, before or immediately after meals.

Ferretts IPS in Children
Results of IPS Treatment in Anemic Children, Mean Age 3-5 Years

Iron Protein Succinylate

• Wide Patient Use
  Over 3,000,000 patients have been treated.
• Full clinical evaluation
  Ca. 3,500 patients have been treated in clinical trials
• Highest Safety Confirmed
  93.7% of subjects reported no side effects

Ferretts IPS Profile Summary

• Ferretts IPS is safe and efficacious. Ferretts IPS contains iron wrapped in a casein protective layer, and does not dissolve in the gastric mucosa.
• Ferretts IPS dissolves in the intestine as ferric iron, the active component is rapidly absorbed.
• Ferretts IPS has a superior safety profile. Ferretts IPS allows long-lasting treatment, as is most often required for iron deficiency anemia.

Each 1 ml contains: . . . . . . . . 2.67 mg Elemental Iron
Each 5 ml contains: . . . . . . . 13.33 mg Elemental Iron
Each 7.5 ml contains: . . . . . . . 20 mg Elemental Iron
Each 10 ml contains: . . . . . . 26.67 mg Elemental Iron
Each 15 ml contains:. . . . . . . . 40 mg Elemental Iron

- From Iron Protein Succinylate

Used with permission © Chemi Nutra 2004

Mailing address: PO Box 27554
Salt Lake City, UT 84127-0554
Street Address: 2702 South 3600 West, Suite H
Salt Lake City, UT 84119
Phone: 801-966-4138, 800-456-4138 FAX: 801-966-4177
Email: service@pharmics.com